Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
19.03
Oct 30 • 3:59 PM ET Dollar change+0.09 Percentage change(0.48%)
Aftermarket Close
19.15
Aftermarket • 7:59 PM ET Dollar change+0.12 Percentage change(0.63%)
Index
S&P 500
Market Cap
13.45B
Enterprise Value
23.70B
Income
242.74M
Sales
2.95B
Book/sh
11.38
Cash/sh
2.43
Employees
411
IPO
Jul 19, 2013
P/E
54.40
Forward P/E
86.24
PEG
2.02
P/S
4.56
P/B
1.67
P/C
7.82
P/FCF
12.13
EV/EBITDA
14.57
EV/Sales
8.03
Quick Ratio
3.40
Current Ratio
3.40
Debt/Eq
1.32
LT Debt/Eq
1.22
Option/Short
Yes / Yes
EPS (ttm)
0.35
EPS next Y
0.22
EPS next Q
0.06
EPS this Y
361.59%
EPS next Y
-52.19%
EPS next 5Y
42.64%
EPS past 3/5Y
-52.08% -
Sales past 3/5Y
11.05% 11.40%
EPS Y/Y TTM
48.98%
Sales Y/Y TTM
5.52%
EPS Q/Q
68.06%
Sales Q/Q
11.12%
Insider Own
0.31%
Insider Trans
-0.50%
Inst Own
99.18%
Inst Trans
-4.78%
ROA
1.17%
ROE
3.08%
ROIC
1.39%
Gross Margin
20.87%
Oper. Margin
17.95%
Profit Margin
8.23%
SMA20
0.81%
SMA50
-4.39%
SMA200
-0.53%
Trades
Shs Outstand
689.47M
Shs Float
687.38M
52W High
22.95 -17.08%
52W Low
15.70 21.21%
Volatility
2.14% 2.37%
ATR (14)
0.46
RSI (14)
46.89
Beta
0.99
Rel Volume
1.20
Avg Volume
5.41M
Volume
6,465,355
Perf Week
-1.14%
Perf Month
-2.11%
Perf Quarter
-12.06%
Perf Half Y
15.90%
Perf YTD
18.35%
Perf Year
8.31%
Perf 3Y
22.00%
Perf 5Y
-44.46%
Perf 10Y
-36.55%
Prev Close
18.94
Price
19.03
Change %
0.48%
Consensus
Buy
Avg. Price Target
$22.29
Implied Upside
+17.1%
Analysts17incl. previous ratings
Rating Distribution5 Buy · 12 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 07, 2026Initiated
BCS logoBBarclays
Equal Weight$23+20.9%
Jun 17, 2026Resumed
RJF logoRRaymond James
Mkt Perform
Jun 11, 2026Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight$22+15.6%
May 11, 2026Downgrade
EVR logoEEvercore ISI
Outperform → In-line$21+10.4%
Apr 20, 2026Initiated
UBS logoUUBS
Neutral$17-10.7%
Feb 05, 2026Downgrade
AArgus
Buy → Hold
Jan 09, 2026Initiated
GS logoGGoldman
Neutral$17-10.7%
Dec 16, 2025Downgrade
JEF logoJJefferies
Buy → Hold$17-10.7%
Oct 01, 2025Initiated
CCantor Fitzgerald
Neutral$20+5.1%
Sep 15, 2025Upgrade
RJF logoRRaymond James
Mkt Perform → Outperform$20+5.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bohn Scott RCDO and Head of LabMay 12 '26Sale19.4510,989213,7407,636May 13 04:30 PM
Bohn Scott ROfficerMay 12 '26Proposed Sale19.4510,989213,741May 12 04:07 PM
Healthpeak Properties, Inc. engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Outpatient Medical, Lab, and Senior Housing. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The Lab segment consists of laboratory and office space. The Senior Housing segment includes life plan communities and unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in March 1985 and is headquartered in Denver, CO.
PresidentMr. Scott M. Brinker
Chief Financial OfficerMr. Kelvin O. Moses
Chief Investment OfficerMr. Adam G. Mabry
Executive VPMs. Tracy A. Porter
Chief Development Officer & Head of LabMr. Scott R. Bohn